SK Inc. may make investment in Center for Breakthrough Medicines
SK Inc. is in final talks to make an investment in the Center for Breakthrough Medicines (CBM), a Philadelphia-based gene and cell therapy company, to build its presence in the global contract manufacturing organization (CMO) market.